Mineralys Therapeutics, Inc.
MLYSPharmaceutical Preparations · SIC 2834 · CIK 0001933414
Revenue FY2025
—
Net Income
$(155.0M)
EPS (Basic)
$-2.29
Net Margin
—
ROE
-23.9%
Total Equity
$647.0M
Shares Out
88M
Mineralys Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2022–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
RA Capital Management
RA Capital Management
$207.6M
1.3%
—
Deerfield Management Company
Deerfield Management Company
$106.8M
0.6%
NEW
OrbiMed Advisors
OrbiMed Advisors
$56.9M
0.3%
+2.8%
Suvretta Capital Management
Suvretta Capital Management
$4.7M
0.1%
(88.7%)
Capital World Investors
Capital World Investors
$53.9M
0.0%
+401.7%
Alps Advisors
Alps Advisors
$2.4M
0.0%
+38.1%
Insider Transactions
Reading stored insider transactions…